ProfileGDS4459 / ENSG00000186090
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 37% 38% 34% 27% 33% 36% 43% 38% 35% 40% 41% 37% 35% 15% 35% 38% 60% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.9937
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.0238
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 33.7234
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 43.7627
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 53.7733
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 63.8936
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.1343
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.8938
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 93.7635
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.0240
GSM623474group B, liver allograft wedge biopsie placebo treatment 1441
GSM623475group B, liver allograft wedge biopsie placebo treatment 23.8237
GSM623476group B, liver allograft wedge biopsie placebo treatment 33.8535
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.2115
GSM623478group B, liver allograft wedge biopsie placebo treatment 53.7635
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.0338
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.7560